Biomedicine Key Laboratory of Shaanxi Province, Northwest University, Xi'an 710069, PR China.
J Ethnopharmacol. 2013 Jan 9;145(1):187-92. doi: 10.1016/j.jep.2012.10.049. Epub 2012 Nov 7.
ETHNOPHARMACOLOGICA RELEVANCE: Picrasma quassiodes (D. Don) Benn. (PQB) is a widely used herbal medicine used for gastroenteritis, snakebite, infection and hypertension in China. The aim of the study was to investigate the possible antihypertensive mechanisms on spontaneously hypertensive rats (SHR) of the extract from Picrasma quassiodes (D. Don) Benn.
In the in vivo study, extract from Picrasma quassiodes (D. Don) Benn. at the dose of 50, 100, 200mg/kg and captopril (12.5mg/kg) were administrated to different group of SHR rats by gavage for six consecutive weeks after the blood pressures were firstly measured. At the end of the study, rats serum nitric oxide (NO) was measured by the nitrate reductase method; superoxide dismutase (SOD) and malondialdehyde (MDA) activities were measured by the colorimetric method; the expression of aorta endothelial nitric oxide synthase (eNOS) was measured by immunohistochemical analysis.
The results showed that the oral administration of PQB could lower the systolic blood pressure (SBP) of SHR rats. In addition, the serum level of NO in SHR treated with PQB (100 and 200mg/kg) was increased dramatically (P<0.05, P<0.01), but administration with captopril had no significant effect. The expression of aorta eNOS was markedly increased when treated with PQB. The serum SOD levels were increased with treatment of PQB (100 and 200mg/kg; P<0.05, P<0.01). All the effects of these parameters were comparable to that of the SHR control group.
Our results disclosed that PQB is effective to lower blood pressure of SHR, its antihypertensive effect is probably associated with lowering oxidative stress by reducing SOD activity, preserving endothelial function and increasing the expression of eNOS to regulate NO and directly relax artery.
研究 Picrasma quassiodes(D. Don)Benn.(PQB)提取物对自发性高血压大鼠(SHR)的可能降压机制。
在体内研究中,将 PQB 提取物以 50、100、200mg/kg 的剂量灌胃不同剂量的 SHR 大鼠,连续 6 周,首次测量血压后。在研究结束时,通过硝酸还原酶法测量大鼠血清中一氧化氮(NO)的含量;通过比色法测量超氧化物歧化酶(SOD)和丙二醛(MDA)的活性;通过免疫组织化学分析测量主动脉内皮型一氧化氮合酶(eNOS)的表达。
结果表明,PQB 的口服给药可降低 SHR 大鼠的收缩压(SBP)。此外,PQB(100 和 200mg/kg)治疗的 SHR 血清中 NO 水平显着升高(P<0.05,P<0.01),但卡托普利治疗则无明显作用。PQB 治疗后主动脉 eNOS 的表达明显增加。PQB(100 和 200mg/kg)治疗后血清 SOD 水平升高(P<0.05,P<0.01)。所有这些参数的作用都与 SHR 对照组相当。
我们的结果表明,PQB 对 SHR 的血压有效,其降压作用可能与降低 SOD 活性降低氧化应激、保持内皮功能和增加 eNOS 的表达以调节 NO 并直接舒张动脉有关。